🇺🇸 FDA
Patent

US 10501428

Thymoquinone derivatives for treatment of cancer

granted A61KA61K31/122A61K31/5375

Quick answer

US patent 10501428 (Thymoquinone derivatives for treatment of cancer) held by UNITED ARAB EMIRATES UNIVERSITY expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED ARAB EMIRATES UNIVERSITY
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/122, A61K31/5375, A61K45/06, A61P